HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristina Daniunaite Selected Research

tetraphenylphosphonium (tetraphenylphosphonium chloride)

1/2021Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristina Daniunaite Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 12/2014
6Prostatic Neoplasms (Prostate Cancer)
01/2019 - 12/2014
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2021 - 01/2015
2Breast Neoplasms (Breast Cancer)
12/2022 - 01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
06/2019
1Lung Neoplasms (Lung Cancer)
06/2017
1Lewis Lung Carcinoma
06/2017
1Neoplasm Metastasis (Metastasis)
12/2014

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
12/2022 - 09/2016
3MicroRNAs (MicroRNA)IBA
06/2017 - 09/2016
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021 - 10/2015
1Proteins (Proteins, Gene)FDA Link
06/2021
1tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1MetallothioneinIBA
06/2019

Therapy/Procedure

3Prostatectomy (Retropubic Prostatectomy)
01/2017 - 12/2014
1Radiotherapy
06/2017
1Therapeutics
12/2014